Simbec Research is a full-service MHRA accredited facility, who conduct Early Phase clinical research studies, including First-in-Human studies (FiH). Based on a single, dedicated research campus, offering a full-service solution. We have expertise in a vast array of drug classes and dosage forms. With over 40 years of operations, Simbec Research is one of the most experienced FIH, and Early Phase Clinical Research Organizationís having successfully delivered over 1500 Phase I/IIa studies.
Part of the Simbec-Orion Group, created in 2014 by the merger of two established CROs; Simbec Research, a specialist CRO in Early Stage Clinical Development and Orion Clinical, the specialist CRO in Late Stage Clinical Development focused on oncology and rare & orphan disease to create an international, full service, boutique CRO.

CCRA is a not-for-profit organisation originally founded to represent independent clinical research contractors and allied industries.